Stock Market News for March 27, 2026
349 news published.
Market activity, travel sector strength and macro cues
Carnival Corporation & PLC (CCL) reported record first‑quarter operating results and bookings, reinforcing resilient leisure demand that’s lifting cyclical travel names.
ICE (ICE) said market activity hit record levels amid Middle East tensions, a reminder geopolitical shocks can boost exchange volumes even as risk appetite wavers.
Clinical progress and dermatology & neuroscience data investors watch
Celldex Therapeutics (CLDX) presented positive Phase 2 AAD data, which could accelerate commercial planning or partnership discussions in urticaria therapies.
Aclaris Therapeutics (ACRS) added validation for ATI‑2138 at AAD, tightening competition in dermatology franchises.
LB Pharmaceuticals (LBRX) presented new analysis from the Phase 2 NOVA‑1 trial at SIRS (details), keeping neuroscience pipeline milestones in investor models.
Eli Lilly (LLY) reported long‑term durability for lebrikizumab in atopic dermatitis (data), a result that reshapes competitive positioning across immunology.
Capital markets, ETF moves and large financings
J.P. Morgan (JPM) will transfer 14 ETFs from current exchanges, a reshuffle likely to alter liquidity and market‑making flows for affected products.
CBL Properties (CBL) closed a $176 million non‑recourse financing, easing near‑term pressure on leverage for mall REITs.
Suncrete and Haymaker Acquisition Corp. 4 (HYAC) upsized a private placement to $167.1 million, while Zenas BioPharma (ZBIO) priced offerings targeting $300.0 million; both moves change dilution and runway calculus for investors.
Corporate strategy, leadership and M&A posture
Teleflex (TFX) reiterated commitment to value‑maximizing strategies while keeping strategic alternatives open (company statement), a stance that often rekindles takeover speculation.
Anaptys (ANAB) continued spin‑out activity after First Tracks commitments and a $100M repurchase, balancing R&D funding with shareholder returns.
Cue Biopharma (CUE) announced a CEO transition, an event that can re‑risk timelines and strategic execution.
AI infrastructure & networking
E‑Power Inc. (EPOW) teamed with Raytel Electronics to launch next‑generation 800G and 1.6T optical modules for AI data centers—an infrastructure play tied to rising compute demand.
FiEE, Inc. (FIEE) plans to invest roughly $3.0 million to build an AI music ecosystem (investment details), illustrating vertical content strategies in generative AI.
Defense, industrial orders and energy moves
Teledyne Technologies (TDY) won a follow‑on order from Sweden’s FMV for GAVIA AUV systems, adding to steady defense demand.
Greenland Energy Company (GLND) secured a strategic agreement for rig capacity to support onshore exploration (deal), which could alter regional capex cadence for explorers.
Product validation and commercial traction
Castle Biosciences (CSTL) reported that DecisionDx‑Melanoma improves risk stratification within AJCC stages, data that may help payer coverage and clinical uptake.
Profound Medical (PROF) celebrated its 100th TULSA procedure at Texas Prostate (milestone), signaling growing procedural adoption.
Consumer fintech, tokenization and partnerships
Moomoo (FUTU) renewed a partnership with the New York Mets to enhance fan engagement (details), a branding play that could lift transaction volumes.
xStocks and Fundrise (VCX) partnered to tokenize the VCX fund, highlighting momentum in asset tokenization.
Earnings, revenue updates and notable annual reports
- BTCS (BTCS) posted 305% YoY revenue growth to $16.5M, noteworthy for crypto‑infrastructure exposure.
- Origin Materials (ORGN) reported operating and financial results for Q4 and full‑year 2025 (details), useful for tracking progress on commercial scale‑up of sustainable materials.
- Electra (ELBM) restarted construction and released 2025 financial results, a signal that project timelines and revenue recognition could shift for developers.
- Magna International (MGA) posted its 2025 annual report, giving investors a fuller view of auto supply chain exposure and capital allocation plans.
Distress, listings and governance actions
BiomX Inc. (PHGE) received a NYSE American notification about stockholders’ equity deficiency, increasing recapitalization pressure.
Sotherly Hotels Inc. (SOHO) plans to voluntarily delist from Nasdaq and move to the OTC market, a liquidity and institutional‑access consequence for shareholders.
Iterum Therapeutics (ITRM) filed a winding‑up petition, shifting focus to creditors and potential asset sales.
Immersion Corporation (IMMR) received a Nasdaq delinquency notice, a governance red flag to monitor for remediation steps.
InMed Pharmaceuticals (INM) received a Nasdaq notice on minimum bid price compliance, a common trigger for reverse split or continued noncompliance risk.
NIP Group Inc. (NIPG) announced receipt of a Nasdaq notice, putting near‑term listing status and investor liquidity under watch.
NextPlat (NXPL) announced a reverse stock split to regain bid‑price compliance—an action that alters float and per‑share math for holders.
Diginex Limited (DGNX) set an EGM to approve a share capital increase and consolidation, steps commonly used to shore up balance sheets but dilutive to existing equity.
Bloomia Holdings (TULP) extended a rights offering, giving current shareholders more time to decide on dilution and funding participation.
Legal, IP and sector‑wide implications
Editas Medicine (EDIT) said the U.S. PTO reaffirmed its decision favoring the Broad Institute in a CRISPR/Cas9 dispute, a ruling with licensing and competitive implications across gene‑editing developers.
Items trimmed or monitoring list
Smaller governance moves and inducement grants—such as Crescent Biopharma’s inducement awards—were deprioritized to keep this bulletin focused on sector‑defining data, large financings and listing risks.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement